Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer’s Disease
- 22 February 2012
- journal article
- research article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 33 (1), 18-28
- https://doi.org/10.1159/000336051
Abstract
Background/Aims: Degeneration of cholinergic neurons in the basal forebrain correlates with cognitive decline in patients with Alzheimer’s disease (AD). Targeted delivery of exogenous nerve growth factor (NGF) has emerged as a potential AD therapy due to its regenerative effects on the basal forebrain cholinergic neurons in AD animal models. Here we report the results of a first-in-man study of encapsulated cell (EC) biodelivery of NGF to the basal forebrain of AD patients with the primary objective to explore safety and tolerability. Methods: This was an open-label, 12-month study in 6 AD patients. Patients were implanted stereotactically with EC-NGF biodelivery devices targeting the basal forebrain. Patients were monitored with respect to safety, tolerability, disease progression and implant functionality. Results: All patients were implanted successfully with bilateral single or double implants without complications or signs of toxicity. No adverse events were related to NGF or the device. All patients completed the study, including removal of implants at 12 months. Positive findings in cognition, EEG and nicotinic receptor binding in 2 of 6 patients were detected. Conclusions: This study demonstrates that surgical implantation and removal of EC-NGF biodelivery to the basal forebrain in AD patients is safe, well tolerated and feasible.Keywords
This publication has 45 references indexed in Scilit:
- Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transferGene Therapy, 2011
- Taking Pain Out of NGF: A “Painless” NGF Mutant, Linked to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic ActivityPLOS ONE, 2011
- Long-term Delivery of Nerve Growth Factor by Encapsulated Cell Biodelivery in the Göttingen Minipig Basal ForebrainMolecular Therapy, 2010
- Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2009
- NGF Is Essential for Hippocampal Plasticity and LearningJournal of Neuroscience, 2009
- Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene deliveryExperimental Neurology, 2009
- Cholinergic system during the progression of Alzheimer’s disease: therapeutic implicationsExpert Review of Neurotherapeutics, 2008
- Identifying Patients at High and Low Risk of Cognitive Decline Using Rey Auditory Verbal Learning Test among Middle-Aged Memory Clinic OutpatientsDementia and Geriatric Cognitive Disorders, 2006
- Kinetic Analysis of Regional (S)(-)11C-Nicotine Binding in Normal and Alzheimer Brains In Vivo Assessment Using Positron Emission TomographyAlzheimer Disease & Associated Disorders, 1995
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984